Brief: Glenmark Life Sciences March-Quarter Profit Falls
April 20 (Reuters) - Glenmark Life Sciences Ltd GLEM.NS :
* GLENMARK LIFE SCIENCES MARCH-QUARTER PROFIT 989 MILLION RUPEES VERSUS 1.05 BILLION RUPEES
YEAR
AGO
* GLENMARK LIFE SCIENCES MARCH-QUARTER REVENUE FROM OPERATIONS 5.14 BILLION RUPEES VERSUS
4.67
BILLION RUPEES YEAR AGO
* GLENMARK LIFE SCIENCES - RECOMMENDED FINAL DIVIDEND OF 10.5 RUPEESPER SHARE
Source text for Eikon: ID:nBSEcf0XbW
Further company coverage: GLEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alivus Life Sciences
See all newsBrief: Alivus Life Sciences Incorporates Subsidiary Alivus Life Sciences Do Brasil Ltda In Brazil
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees